Listing Websites about Arena Pharmaceuticals
Home - Arena Pharmaceuticals, Inc.
(7 days ago) Arena Pharmaceuticals is a team with a singular focus–deliver important medicines* to patients. The global market is changing rapidly. Keeping up isn’t enough. You’ve got to stay ahead. This is the urgency that drives us day after day to understand stakeholders, to identify bold—even disruptive—ideas that will get medicines to
ARNA Stock Price Arena Pharmaceuticals Inc. Stock Quote
(8 days ago) Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It …
Arena Pharmaceuticals, Inc. (ARNA) Company Profile & Facts
(4 days ago) Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah. Corporate Governance Arena Pharmaceuticals, Inc.’s ISS Governance QualityScore as of September 26, 2021 is 4.
Home Arena Pharmaceuticals (en-US)
(1 days ago) Join clinical study for Crohn’s disease. If you live with Crohn’s disease, you may be able to take part in clinical study investigating a potential new treatment. Please choose your country and language to find your local website.
Arena Pharmaceuticals Company Profile - Office Locations
(8 days ago) Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors (GPCRs) to address unmet medical needs. The Company’s most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension
(9 days ago) From our base in Central England, Arena Pharmaceuticals source, procure, store and supply high quality APIs from our global network to meet your complex regulatory needs. Established in 2001, we have built a strong and highly experienced team to become a leading supplier of APIs for the pharmaceutical, veterinary and health food markets
Is Arena Pharmaceuticals Inc.’s -24.89% Fall This Year Is
(7 days ago) Arena Pharmaceuticals Inc. (ARNA) estimates and forecasts. Statistics highlight that Arena Pharmaceuticals Inc. is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -12.22% of value to its shares in past 6 months, showing an annual growth rate of -19.49% while that of industry is 6.90.
Arena Pharmaceuticals' Grants & Giving Portal
(2 days ago) Arena supported event, activity, person or organization focused on humanitarian, social, education and community programs Learn More Please be aware that Arena Pharmaceuticals' acceptance of a request is dependent upon a number of factors including, but not limited to, scientific merit, company goals, and availability of resources/funding.
Arena Pharmaceuticals Reports Inducement Grants Under
(4 days ago) ARENA Pharmaceuticals is a team with a singular purpose – deliver important medicines to patients. In a rapidly changing global market, we work with a sense of urgency every day to understand
ARNA.O - Arena Pharmaceuticals, Inc. Profile Reuters
(Just Now) About Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas.
Arena Pharmaceuticals - Crunchbase Company Profile & Funding
(1 days ago) Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name Arena Pharmaceuticals, Inc. Stock Symbol NASDAQ:ARNA. Company Type For Profit. Contact Email [email protected] Phone Number 858-453-7200. Clinical-stage biotech focused on cardiovascular, central nervous system, inflammatory and metabolic diseases. Their leading drug
ARNA Stock Forecast, Price & News (Arena Pharmaceuticals)
(6 days ago) Arena Pharmaceuticals' stock was trading at $40.42 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ARNA stock has increased by 55.6% and is now trading at $62.89. View which stocks have been most impacted by COVID-19.
Arena Pharmaceuticals’s Competitors, Revenue, Number of
(Just Now) Arena Pharmaceuticals has 194 employees and is ranked 3rd among it's top 10 competitors. The top 10 competitors average 116. VIVUS is Arena Pharmaceuticals's #1 rival. VIVUS is a Public company that was founded in Campbell, California in 1991. Like Arena Pharmaceuticals, VIVUS also works within the Biotechnology field.
89 Salaries at Arena Pharmaceuticals Shared by Employees
(4 days ago) The average Arena Pharmaceuticals salary ranges from approximately $85,983 per year for a Research Associate to $207,341 per year for an Associate Director. Arena Pharmaceuticals employees rate the overall compensation and benefits package 4.0/5 stars. What is the highest salary at Arena Pharmaceuticals?
Arena Pharmaceuticals Company Profile Management and
(4 days ago) Arena Pharmaceuticals conducts research on and develops pharmaceutical solutions for the use of treating bodily diseases. Some of the diseases their pharmaceuticals are used to treat include Crohn's disease, atopic dermatitis, ulcerative colitis, and more. This company is headquartered in San Diego, California and was founded in 1997.
Arena Pharmaceuticals Company Profile: Stock Performance
(7 days ago) Arena Pharmaceuticals General Information Description. Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to …
Arena Pharmaceuticals Announces Launch of Longboard
(7 days ago) About Arena Pharmaceuticals ARENA Pharmaceuticals is a team with a singular purpose – deliver our important medicines to patients. In a rapidly changing global market, we work with a …
Arena Pharmaceuticals – The Cannabis Science Blog
(8 days ago) Other companies, including Arena Pharmaceuticals, are attempting to develop cannabis-based drugs and mimetics that treat pain by binding to certain types of cannabis receptors found throughout the body (3). Removing cannabis’ psychotropic effects and preserving its pain-relieving benefits is the major objective for this new class of
Arena Pharmaceuticals - Overview, News & Competitors
(Just Now) Description. Arena Pharmaceuticals conducts research on and develops pharmaceutical solutions for the use of treating bodily diseases Read More. Headquarters: 6154 Nancy Ridge Dr, San Diego, California, 92121, United States. Phone: (858) 453-7200. Website: www.arenapharm.com.
Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi
(Just Now) Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) 39th Annual J.P. Morgan Healthcare Conference January 13, 2021 1:00 PM ET Company Participants. Amit Munshi - President and Chief Executive Officer
Ulcerative Colitis Study Arena Pharmaceuticals (en-US)
(5 days ago) Join clinical study for Crohn’s disease. If you live with Crohn’s disease, you may be able to take part in clinical study investigating a potential new treatment. Please choose your country and language to find your local website.
United Therapeutics Announces Closing Of - UTHR PIPELINE
(4 days ago) RESEARCH TRIANGLE PARK, N.C., Jan. 24, 2019 /PRNewswire/ United Therapeutics Corporation (Nasdaq: UTHR) today announced the closing of the transactions contemplated by its license agreement with Arena Pharmaceuticals, Inc. (Nasdaq: ARNA). Under the agreement, United Therapeutics acquired exclusive, worldwide rights to develop and manufacture the Phase 3 …
Arena Pharmaceuticals (NASDAQ:ARNA) Stock Price, News
(5 days ago) Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U
Celgene Buys Receptos. Is Arena Pharmaceuticals Next
(5 days ago) Arena Pharmaceuticals (NASDAQ: ARNA) jumped more than 6% last Wednesday. But it had nothing to do with the biotech's only approved drug, obesity treatment Belviq. It wasn't even anything Arena
Arena Pharmaceuticals Stock Quote: ARNA Stock News, Quotes
(1 days ago) Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on July 16, 2021, the Compensation Committee of its Board of Directors granted to 17 new employees inducement stock options to purchase an aggregate of 45,200 shares of its common stock and 20,235 inducement restricted stock units. Business Wire 07/22/2021 04:05 PM ET.
FAQ about Arena Pharmaceuticals
What do you need to know about Arena Pharmaceuticals?
ARENA is a team with a singular purpose – deliver our important medicines to patients. Care More. Act Differently. We are a biopharmaceutical company focused on developing novel, small molecule drugs with optimized receptor pharmacology designed to deliver broad clinical utility across multiple therapeutic areas.
What's the stock price of Arna Arena Pharmaceuticals?
ArenaPharmaceuticals $ARNA BidaskScore is Lowered to Sold bidaskclub.com/news/company... $NLST I was never as excited on another stock like this except for $ARNA when I bought in at $1.80, not even $IDIX comes close!
Who is the CFO of Arena Pharmaceuticals?
PARK CITY, Utah, Jun 14, 2021--Steven Schoch, CFO of 23andMe, appointed to Arena Pharmaceuticals' Board of Directors and as Chair of the Audit Committee. The FDA bestows an Orphan Drug status to Arena's (ARNA) lead pipeline candidate, etrasimod, for the treatment of eosinophilic esophagitis.
What is the sentiment score for Arena Pharmaceuticals?
Arena Pharmaceuticals earned a daily sentiment score of -2.8 on InfoTrie's scale. They also gave news articles about the biopharmaceutical company a news buzz of 9.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future.